Home Site Map Search Contact Us

About Neotropix	Products	Technology	Partnering	News and Events	Careers

	Discover. Develop. Deliver. Realizing the Promise.
Neotropix™ Inc. develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers, such as small cell lung cancer and neuroblastoma. Capitalizing on its unique sources of naturally occurring viruses that selectively target tumors, the Company has the knowledge and skills to translate these discoveries into commercial products. Neotropix is committed to discovering innovative cancer treatments that make a difference in the lives of cancer patients.

Neotropix – A Leading Biotechnology Company Committed to Making a Difference in the Lives of Cancer Patients Through Innovative Lung Cancer Treatments & Much More!

Inside Neotropix

Many viruses have evolved, over billions of years, to do exactly what is needed to create effective cancer therapies: kill tumor cells but not normal cells. Neotropix works to harness viruses' natural properties to treat cancer and other diseases that are resistant to available therapeutic methods.

Neotropix began a Phase I/IIa Clinical Trial on our first cancer drug candidate in May, 2006.

We urge you to explore Neotropix and learn about our work in small cell lung cancer and other cancers as a leading biotechnology company in the emerging field of virotherapy.

Neotropix is at the forefront of research and treatment in specific areas such as small cell lung cancer, neuroendocrine non-small cell lung cancer, (including large cell lung cancer), carcinoid and multiple pediatric cancers, such as neuroblastoma, rhabdomyosarcoma, retinoblastoma, medulloblastoma, glioblastoma, rhabdoid tumors, and Wilms’ tumors.

Product Spotlight

NTX-010: NTX-010 is a novel naturally-occurring virus that is being developed as an innovative cancer treatment. NTX-010 specifically attacks and kills neuroendocrine cancers, such as small cell lung cancer, small cell carcinomas originating in other organs, carcinoid, neuroblastoma and certain other neuroendocrine cancers.